Results 21 to 30 of about 1,036,342 (307)

Introduction to Antibody-Drug Conjugates

open access: yesAntibodies, 2021
Antibody-drug conjugates (ADCs) are innovative biopharmaceutical products in which a monoclonal antibody is linked to a small molecule drug with a stable linker.
Mark C. Pettinato
doaj   +1 more source

Click Chemistry and Multicomponent Reaction for Linker Diversification of Zinc Dipicolylamine-Based Drug Conjugates

open access: yesFrontiers in Chemistry, 2022
An efficient Ugi multicomponent reaction with strain promoted azide-alkyne cycloaddition protocol has been utilized in concert or independently to prepare a small family of bioactive zinc(II) dipicolylamine (ZnDPA)-based SN-38 conjugates. With sequential
Ching-Hua Tsai   +7 more
doaj   +1 more source

Design, Synthesis, and Cytotoxic Evaluation of Novel Tubulysin Analogues as ADC Payloads [PDF]

open access: yesACS Medicinal Chemistry Letters, 2016
The tubulysin class of natural products has attracted much attention from the medicinal chemistry community due to its potent cytotoxicity against a wide range of human cancer cell lines, including significant activity in multidrug-resistant carcinoma models. As a result of their potency, the tubulysins have become an important tool for use in targeted
Carolyn A, Leverett   +15 more
openaire   +2 more sources

Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences

open access: yesExploration of Targeted Anti-tumor Therapy, 2022
Antibody-drug conjugates (ADCs) are a recent, revolutionary approach for malignancies treatment, designed to provide superior efficacy and specific targeting of tumor cells, compared to systemic cytotoxic chemotherapy.
Marilia Barreca   +5 more
doaj   +1 more source

Progresses in research and development of antibody-drug conjugate

open access: yes生物医学转化, 2021
Through referring to the literature and related databases, the research process of antibodyconjugated drugs was reviewed, and the key elements of ADC were summarized.
Wu Gang   +6 more
doaj   +1 more source

High-performance payload data handling system for Gaia [PDF]

open access: yes, 2006
Gaia is the most ambitious space astrometry mission currently envisaged and is a technological challenge in all its aspects. We describe a proposal for the payload data handling system of Gaia, as an example of a high-performance, real-time, concurrent ...
Luri Carrascoso, Xavier   +2 more
core   +1 more source

Yasir-ali-farrukh/Payload-Byte: V1.0

open access: yes, 2022
Payload-Byte is a tool for extracting and labeling packet capture (Pcap) files of modern network intrusion detection ...
SyedWaliAbbas   +2 more
core   +1 more source

Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness Payday with a Targeted Payload

open access: yesPharmaceutics, 2023
Antibody–drug conjugates (ADCs) are at the forefront of the drug development revolution occurring in oncology. Formed from three main components—an antibody, a linker molecule, and a cytotoxic agent (“payload”), ADCs have the unique ability to deliver ...
A. Kondrashov   +5 more
semanticscholar   +1 more source

Spectrally compact optical subcarrier multiplexing with 42.6 Gbit/s AM-PSK payload and 2.5Gbit/s NRZ labels [PDF]

open access: yes, 2006
A novel approach to optical subcarrier multiplexing with compact spectrum is demonstrated using a 42.6 Gbit/s AM-PSK payload and 2.5 Gbit/s NRZ label. In this implementation, the payload introduces a 4.8 dB penalty on the label receiver sensitivity, and ...
Barry, Liam P.   +5 more
core   +2 more sources

NAV-001, a high-efficacy antibody-drug conjugate targeting mesothelin with improved delivery of a potent payload by counteracting MUC16/CA125 inhibitory effects

open access: yesPLoS ONE, 2023
Subsets of tumor-produced cell surface and secreted proteins can bind to IgG1 type antibodies and suppress their immune-effector activities. As they affect antibody and complement-mediated immunity, we call these proteins humoral immuno-oncology (HIO ...
N. Nicolaides, J. Kline, L. Grasso
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy